Petri Polonen

21PUBLICATIONS
276CO-AUTHORS
Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)Innate immunityEpigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 02, 2026
Multimodal analysis of CD38 in T-cell Acute Lymphoblastic Leukemia Identifies Combinatorial Therapeutic Strategies.

|Apr 09, 2026
Genomic Insights into the Biology of T-lineage Acute Lymphoblastic Leukemia.

Petri Pölönen, David T Teachey, Charles G Mullighan

|Apr 06, 2026
The ASH HematOmics Program supports integrative analysis of genomic and clinical data in hematologic diseases.

Congyu Lu, Gavriel Y Matt, Robin Paul

|Mar 06, 2026
Deregulation of FOXF1/FENDRR from t(14;16)(q32;q24) defines a subtype of high-risk lineage ambiguous leukemia.

Danika Di Giacomo, Petri Pölönen, Valentina Bardelli

|Feb 11, 2026
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia.

Jason Xu, Michael McCoy, Zachary Martinez

|Nov 21, 2025
Remodeling of the immune microenvironment is linked to adverse outcome in pediatric T cell acute lymphoblastic leukemia.

Caroline R M Wiggers, Eugene Y Cho, Merve Ozdemir

Pageof 4

Frequent Collaborators

21 joint publications

Charles Mullighan

16 joint publications

David Trent Teachey

10 joint publications

Stanley Pounds

10 joint publications

Kai Tan